97 related articles for article (PubMed ID: 17522857)
1. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?
Basu S; Alavi A
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1527-9. PubMed ID: 17522857
[No Abstract] [Full Text] [Related]
2. Improvement in lesion detection with whole-body oncologic time-of-flight PET.
El Fakhri G; Surti S; Trott CM; Scheuermann J; Karp JS
J Nucl Med; 2011 Mar; 52(3):347-53. PubMed ID: 21321265
[TBL] [Abstract][Full Text] [Related]
3. Joint solution for PET image segmentation, denoising, and partial volume correction.
Xu Z; Gao M; Papadakis GZ; Luna B; Jain S; Mollura DJ; Bagci U
Med Image Anal; 2018 May; 46():229-243. PubMed ID: 29627687
[TBL] [Abstract][Full Text] [Related]
4. Sparsity Constrained Mixture Modeling for the Estimation of Kinetic Parameters in Dynamic PET.
Lin Y; Haldar JP; Li Q; Conti PS; Leahy RM
IEEE Trans Med Imaging; 2014 Jan; 33(1):173-85. PubMed ID: 24216681
[TBL] [Abstract][Full Text] [Related]
5. Dual time point [18F]Flurodeoxyglucose (FDG) Positron Emission Tomography (PET)/Computed Tomography (CT) with water gastric distension in differentiation between malignant and benign gastric lesions.
Farghaly H; Alshareef M; Alqarni A; Sayed M; Nasr H
Eur J Radiol Open; 2020; 7():100268. PubMed ID: 32964074
[TBL] [Abstract][Full Text] [Related]
6. Clinical Value of Combining
Sookha RR; Zhi W; Shen Y; Lazare C; Wang L; Meng Y; Cao C; Hu J; Wu P
J Cancer; 2018; 9(17):3101-3108. PubMed ID: 30210633
[No Abstract] [Full Text] [Related]
7. Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer.
Baun C; Falch K; Gerke O; Hansen J; Nguyen T; Alavi A; Høilund-Carlsen PF; Hildebrandt MG
BMC Med Imaging; 2018 May; 18(1):11. PubMed ID: 29743027
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/computed Tomography in the Follow-up of Colorectal Cancer: Searching off Approaches Increasing Specificity for Detection of Recurrence.
Ince S; Okuyucu K; Hancerliogulları O; Alagoz E; San H; Arslan N
Radiol Oncol; 2017 Dec; 51(4):378-385. PubMed ID: 29333115
[TBL] [Abstract][Full Text] [Related]
9. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
Mena E; Sheikhbahaei S; Taghipour M; Jha AK; Vicente E; Xiao J; Subramaniam RM
Clin Nucl Med; 2017 Jan; 42(1):e16-e21. PubMed ID: 27819858
[TBL] [Abstract][Full Text] [Related]
11. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
Dubreuil J; Giammarile F; Rousset P; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364
[TBL] [Abstract][Full Text] [Related]
12. Standardized Uptake Values from PET/MRI in Metastatic Breast Cancer: An Organ-based Comparison With PET/CT.
Pujara AC; Raad RA; Ponzo F; Wassong C; Babb JS; Moy L; Melsaether AN
Breast J; 2016 May; 22(3):264-73. PubMed ID: 26843433
[TBL] [Abstract][Full Text] [Related]
13. Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PET.
Karakatsanis NA; Zhou Y; Lodge MA; Casey ME; Wahl RL; Zaidi H; Rahmim A
Phys Med Biol; 2015 Nov; 60(22):8643-73. PubMed ID: 26509251
[TBL] [Abstract][Full Text] [Related]
14. Dual time point fluorodeoxyglucose positron emission tomography/computed tomography in differentiation between malignant and benign lesions in cancer patients. Does it always work?
Saleh Farghaly HR; Mohamed Sayed MH; Nasr HA; Abdelaziz Maklad AM
Indian J Nucl Med; 2015; 30(4):314-9. PubMed ID: 26430314
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Impact of Plasma Clearance and Down-regulation on GLP-1 Receptor Molecular Imaging.
Zhang L; Thurber GM
Mol Imaging Biol; 2016 Feb; 18(1):79-89. PubMed ID: 26194012
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging.
Leccisotti L; Perna F; Lago M; Leo M; Stefanelli A; Calcagni ML; Pelargonio G; Narducci ML; Bencardino G; Bellocci F; Giordano A
J Nucl Cardiol; 2014 Jun; 21(3):622-32. PubMed ID: 24715624
[TBL] [Abstract][Full Text] [Related]
17. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes.
Choi H; Yoon HJ; Kim TS; Oh JH; Kim DY; Kim SK
Nucl Med Commun; 2013 Dec; 34(12):1166-73. PubMed ID: 24128896
[TBL] [Abstract][Full Text] [Related]
18. Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study.
Abdulla S; Salavati A; Saboury B; Basu S; Torigian DA; Alavi A
Eur J Nucl Med Mol Imaging; 2014 Feb; 41(2):350-6. PubMed ID: 24085504
[TBL] [Abstract][Full Text] [Related]
19. SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions.
Kwee TC; Cheng G; Lam MG; Basu S; Alavi A
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1475-7. PubMed ID: 23801170
[No Abstract] [Full Text] [Related]
20. Dual time point based quantification of metabolic uptake rates in 18F-FDG PET.
den Hoff Jv; Hofheinz F; Oehme L; Schramm G; Langner J; Beuthien-Baumann B; Steinbach J; Kotzerke J
EJNMMI Res; 2013 Mar; 3(1):16. PubMed ID: 23497553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
